Investigational Drug Information for KW-6356
✉ Email this page to a colleague
What is the drug development status for KW-6356?
KW-6356 is an investigational drug.
There have been 8 clinical trials for KW-6356.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 29th 2018.
The most common disease conditions in clinical trials are Parkinson Disease, Liver Diseases, and [disabled in preview]. The leading clinical trial sponsors are Kyowa Kirin Co., Ltd., Kyowa Hakko Kirin Co., Ltd, and Kyowa Kirin Pharmaceutical Development, Inc.
Summary for KW-6356
US Patents | 0 |
International Patents | 162 |
US Patent Applications | 31 |
WIPO Patent Applications | 7 |
Japanese Patent Applications | 2 |
Clinical Trial Progress | Phase 2 (2018-09-29) |
Vendors | 6 |
Recent Clinical Trials for KW-6356
Title | Sponsor | Phase |
---|---|---|
A Through QT/QTc Study of KW-6356 | Kyowa Kirin Co., Ltd. | Phase 1 |
Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major Metabolite | Kyowa Kirin Pharmaceutical Development, Inc. | Phase 1 |
Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major Metabolite | Kyowa Kirin, Inc. | Phase 1 |
Clinical Trial Summary for KW-6356
Top disease conditions for KW-6356
Top clinical trial sponsors for KW-6356
US Patents for KW-6356
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for KW-6356
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
KW-6356 | Australia | AU2010242375 | 2029-04-28 | ⤷ Try a Trial |
KW-6356 | Brazil | BRPI1011768 | 2029-04-28 | ⤷ Try a Trial |
KW-6356 | Canada | CA2760048 | 2029-04-28 | ⤷ Try a Trial |
KW-6356 | Chile | CL2011002650 | 2029-04-28 | ⤷ Try a Trial |
KW-6356 | China | CN102414209 | 2029-04-28 | ⤷ Try a Trial |
KW-6356 | China | CN104557904 | 2029-04-28 | ⤷ Try a Trial |
KW-6356 | China | CN104606190 | 2029-04-28 | ⤷ Try a Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |